Efficacy and Safety of Traditional Chinese Medicine (Shenqi Particle) for Patients With Idiopathic Membranous Nephropathy: A Multicenter Randomized Controlled Clinical Trial-Reference-Cited by-同舟云学术

Efficacy and Safety of Traditional Chinese Medicine (Shenqi Particle) for Patients With Idiopathic Membranous Nephropathy: A Multicenter Randomized Controlled Clinical Trial

Published:2013-12 Issue:6 Volume:62 Page:1068-1076
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Chen Yiping,Deng Yueyi,Ni Zhaohui,Chen Nan,Chen Xiangmei,Shi Wei,Zhan Yongli,Yuan Fahuan,Deng Wei,Zhong Yifei

Publisher

Elsevier BV

Subject

Nephrology

Reference25 articles.

1. The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey;Glassock;Am J Kidney Dis,2010

2. Diagnosis and natural course of membranous nephropathy;Glassock;Semin Nephrol,2003

3. Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study;Maisonneuve;Am J Kidney Dis,2000

4. Idiopathic membranous nephropathy: diagnosis and treatment;Fervenza;Clin J Am Soc Nephrol,2008

5. Wegener granulomatosis: an analysis of 158 patients;Hoffman;Ann Intern Med,1992

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis and Treatment of Membranous Nephropathy in Integrative Medicine;Integrative Medicine in Nephrology and Andrology;2024-07-08

2. Efficacy and safety of Yiqi Peiyuan granules for improving the short-term prognosis of patients with acute kidney injury: A multicenter, double-blind, placebo-controlled, randomized trial;Journal of Integrative Medicine;2024-05

3. Traditional Chinese medicine for idiopathic membranous nephropathy: A systematic review and meta-analysis;Heliyon;2024-04

4. Efficacy and safety of Mahuang Fuzi and Shenzhuo Decoction for treatment of primary membranous nephropathy: a multicenter prospective trial;Renal Failure;2024-03-14

5. Analysis of the regulating PI3K/AKT/mTOR signaling pathway and anti-apoptosis activity of Shenqi granule through Network Pharmacology and in vitro experiments;2024-01-03